anti-CD7 CAR T-cell Therapy(National University Hospital)

N/A

Report date: 2022/07/19 15:12:25

Base Information

Drug Nameanti-CD7 CAR T-cell Therapy(National University Hospital)

Drug Alias Nameanti-CD7 CAR T-cell

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsAnti-CD7

TargetsT-cell antigen CD7

Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNational University Hospital (Singapore)

China Registration ClassN/A

Develop Information

Active CompaniesNational University Hospital (Singapore)

Inactive CompaniesN/A

Active IndicationsPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphoid

Inactive IndicationsN/A

Other Information

ATC CodeN/A